Silver Book Fact

Annual Direct and Indirect Costs of Diabetic Retinopathy

Fact image

Rein D, Zhang P, Wirth K, et al. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Ophthalmol. 2006; 124(12): 1754-60. http://archopht.jamanetwork.com/article.aspx?articleid=418866

Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs. Diabetic Medicine. 2010; 29: 855-62. https://jdrf.org.uk/wp-content/uploads/2015/10/Hex-and-Bartlett.pdf

Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L. Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden. Diabetologia. 2010; 53(10): 2147-54. http://link.springer.com/article/10.1007%2Fs00125-010-1836-3

Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J. The Economic Burden of Diabetic Retinopathy in Germany in 2002. Graefes Arch Clin Exp Ophthalmol. 2008; 246(1): 151-9. http://link.springer.com/article/10.1007%2Fs00417-007-0573-x

Gonzalez J, Walker J, Einarson T. Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia. 2009; 26(1): 55-63. http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892009000700009

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Ophthalmol
Publication Date
2006
Authors
Rein D, Zhang P, Wirth K, et al
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource
Title
Estimating the Current and Future Costs of Type 1 and Type 2 Diabetes in the UK: Including direct health costs and indirect societal and productivity costs
Publication
Diabetic Medicine
Publication Date
2010
Authors
Hex N, Bartlett C, Wright D, Taylor M, Varley D
Pages
855-62
URL
Read Full Resource
Title
Prevalence and Healthcare Costs of Diabetic Retinopathy: A population-based register study in Sweden
Publication
Diabetologia
Publication Date
2010
Authors
Heintz E, Wirehn A, Peebo B, Rosenqvist U, Levin L
Volume & Issue
Volume 53, Issue 10
Pages
2147-54
URL
Read Full Resource
Title
The Economic Burden of Diabetic Retinopathy in Germany in 2002
Publication
Graefes Arch Clin Exp Ophthalmol
Publication Date
2008
Authors
Happich M, Reitberger U, Breitscheidel L, Ulbig M, Watkins J
Volume & Issue
Volume 246, Issue 1
Pages
151-9
URL
Read Full Resource
Title
Cost-of-Illness Study of Type 2 Diabetes Mellitus in Colombia
Publication Date
2009
Authors
Gonzalez J, Walker J, Einarson T
Volume & Issue
Volume 26, Issue 1
Pages
55-63
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • U.S. health care use attributable to diabetes by medical condition (in thousands)  
  • Projected impact of changing demographic characteristics on the national cost of diabetes: 2002 – 2020 (in 2002 billions of dollars)  
  • Age distribution of deaths associated with diabetes  
  • Annual health care spending attributable to prediabetes or diabetes could rise from $206 billion in 2011 to $512 billion by 2021, with a cumulative cost of approximately $3.5 trillion.  
  • From 2009 – 2012, 71% of adults with diabetes had high blood pressure or used medications to lower their HBP.